Overactive Bladder - Results from #1060

A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life October 30, 2017

New Devices and Technologies for the Management of Overactive Bladder October 24, 2017

[Overactive bladder-which treatment when?] October 24, 2017

Association between coronary artery disease severity and overactive bladder in geriatric patients October 24, 2017

Inflammatory Urinary Cytokine Expression and Quality of Life in Patients With Overactive Bladder October 24, 2017

[Outcomes of transcutaneous posterior tibial nerve stimulation for overactive bladder in diabetic patients] October 17, 2017

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate October 17, 2017

Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women? October 17, 2017

Safety issues associated with using medication to treat overactive bladder October 17, 2017

Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity October 16, 2017

Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory October 8, 2017

No. 353-Treatments for Overactive Bladder: Focus on Pharmacotherapy - An Addendum October 8, 2017

Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study October 8, 2017

Effect of combined solifenacin and aclatonium in preventing dry mouth in patients with overactive bladder October 8, 2017

Development of a core set of outcome measures for OAB treatment October 8, 2017

Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers: Are we doing enough? October 8, 2017

Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women October 1, 2017

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder October 1, 2017

Overactive Bladder Symptoms in Female Health Profession Students: Bladder Diary Characteristics and Impact of Symptoms on Health-Related Quality of Life October 1, 2017

Is There a Relationship Between Patient-Reported Satisfaction and Persistence on Overactive Bladder Syndrome Pharmacotherapy? October 1, 2017

Page 54 of 122